Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bologna
Clinical trial register · Italy

Clinical Trials in Bologna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 60 Roma 44 Bologna 26 Rozzano 20 Naples 20
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna306 Istituto Ortopedico Rizzoli106 AstraZeneca45 Eli Lilly and Company30 Janssen Research & Development, LLC26 Clear sponsor filter
Site location
Milan60 Roma44 Bologna26 Rozzano20 Naples20
All 86 locations
Target enrolment
to

Trials with a site in Bologna

26 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Bologna, Bolzano, Genova, Milan, Roma, Rozzano, Torino
2026-04-21
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Bergamo, Bologna, Cuneo, Florence, Palermo, Pavia, Pescara, Roma
2026-02-08
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Bologna, Florence, Milan, Negrar-Verona, Roma, Rozzano, San Giovanni Rotondo
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bergamo, Bologna, Brescia, Meldola, Milan, Pavia, Perugia, Pesaro
2025-06-04
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Bergamo, Bologna, Roma, San Giovanni Rotondo, Trieste
2024-10-29
Active, closed
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT06470438Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL
Janssen Research & Development, LLC
Phase 1
58
Bologna
2024-05-28
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Alessandria, Bergamo, Bologna, Florence, Milan, Roma
2024-03-13
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bergamo, Bologna, Florence, Pescara, Roma, San Giovanni Rotondo, Trieste
2024-01-19
Recruiting
Janssen Research & Development, LLC
Phase 1
300
Bologna, Milan
2023-12-20
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Arezzo, Aversa, Bergamo, Bologna, Caserta, Catania, Catanzaro, Ferrara
2023-04-11
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Bologna, Milan, Palermo, Pisa, Reggio Emilia, Roma, Siena, Turin
2023-03-29
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bergamo, Bologna, Florence, Milan, Naples, Pavia, Roma, Rozzano
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Ancona, Bari, Bologna, Brescia, Catania, Milan, Padova, Palermo
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Bologna, Meldola, Milan, Rozzano
2022-10-04
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Bari, Bologna, Milan, Orbassano, Padova, Ravenna, Roma, Rome
2022-08-05
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bologna, Milan, Roma
2022-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bologna, Catania, Meldola, Milan, Monza, Ravenna, Roma, Rozzano
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Bergamo, Bologna, Milan
2020-09-17
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Bologna, Milan, Roma, Turin
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Bologna, Milan, Negrar, Padova, Palermo, Rho, Roma, Rozzano
2019-09-26
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
120
Ancona, Bologna, Cagliari, Padova, Reggio Emilia
2018-07-11
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bologna, Cagliari, Cento, Messina, Milan, Padova, Roma, Rome
2018-04-13
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bologna

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Bologna that also match the filters currently applied.

How many clinical trials are recruiting in Bologna?

8 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bologna), 26 studies
PhaseStudiesRecruitingShare
Phase 319773.1%
Phase 13111.5%
Phase 2207.7%
Phase 2/3207.7%

Most active sponsors

Lead sponsors with the most studies (Bologna)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC268
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.